Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Edendale Hospital, Pietermaritzburg, KwaZulu-Natal, South Africa
Colorado State University, Fort Collins, Colorado, United States
General Hospital Maria Middelares, Ghent, Oost-Vlaanderen, Belgium
Helse Fonna, Haugesund Sykehus, Haugesund, Norway
Infant Jesus Teaching Hospital, Warsaw, Poland
Regional Hospital Center of ORLEANS, Orléans, France
Ghent University Hospital, Ghent, Belgium
Xuanwu Hospital, Beijing, Beijing, China
University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.